Posted in | News | Nanoanalysis

Malvern Instruments Announce 1000th Scientific Paper Citing NanoSight Nanoparticle Tracking Analysis

Malvern Panalytical reports on the publication of the 1000th peer-reviewed paper to cite the company’s NanoSight Nanoparticle Tracking Analysis, NTA. Entitled “Fumed Silica Nanoparticle Mediated Biomimicry for Optimal Cell-Material Interactions for Artificial Organ Development,” it was authored by the research team of Professor Alexander Seifalian from University College London.

Alexander Seifalian is Professor of Nanotechnology and Regenerative Medicine at UCL Centre for Nanotechnology and Regenerative Medicine within the Division of Surgery and Interventional Science at University College London, UK. His research focus is on the development of human organs using nano composite materials and stem cells as well as treatment of cancer using nanoparticles. With nanoparticles requiring rapid and repeatable measurement, Professor Seifalian selected Malvern Panalytical’s NanoSight Nanoparticle Tracking Analysis (NTA) system. Previous to this, he had used techniques including scanning electron microscopy (SEM) and atomic force microscopy (AFM) but found that NTA made measuring size easier and more accurate.

Professor Seifalian’s paper, "Fumed Silica Nanoparticle Mediated Biomimicry for Optimal Cell-Material Interactions for Artificial Organ Development” published in the Journal of Macromolecular Biosciences (WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim), was the 1000th peer-reviewed item to be published where results from NTA are cited. In the paper, a fumed silica nanoparticle mediated procedure of scaffold functionalization is described which can be potentially adapted with multiple bioactive molecules to induce cellular biomimicry in the development of human organs. The proposed nanocomposite materials are already in patient use for implants including the world’s first synthetic trachea, tear ducts and coronary and vascular bypass grafts.

Nanoparticle Tracking Analysis detects and visualizes populations of nanoparticles in liquids down to 10 nm, dependent on material, and measures the size of each particle from direct observations of diffusion. Additionally, NTA measures concentration while a fluorescence mode differentiates suitably-labelled particles within complex background suspensions.

This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner. NTA has a growing role in biodiagnostics, being proven in detection and speciation of extracellular vesicles.

NanoSight NTA systems are part of Malvern Panalytical’s extensive portfolio of solutions for the characterization of nanomaterials. To find out about particle characterization using Malvern Panalytical’s unique nanoparticle tracking analysis solutions, visit http://www.malvern.com/nanoparticle-tracking-analysis.

Malvern Panalytical, Malvern Panalytical and NanoSight are registered trademarks of Malvern Panalytical.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2019, February 11). Malvern Instruments Announce 1000th Scientific Paper Citing NanoSight Nanoparticle Tracking Analysis. AZoNano. Retrieved on November 23, 2024 from https://www.azonano.com/news.aspx?newsID=29896.

  • MLA

    Malvern Panalytical. "Malvern Instruments Announce 1000th Scientific Paper Citing NanoSight Nanoparticle Tracking Analysis". AZoNano. 23 November 2024. <https://www.azonano.com/news.aspx?newsID=29896>.

  • Chicago

    Malvern Panalytical. "Malvern Instruments Announce 1000th Scientific Paper Citing NanoSight Nanoparticle Tracking Analysis". AZoNano. https://www.azonano.com/news.aspx?newsID=29896. (accessed November 23, 2024).

  • Harvard

    Malvern Panalytical. 2019. Malvern Instruments Announce 1000th Scientific Paper Citing NanoSight Nanoparticle Tracking Analysis. AZoNano, viewed 23 November 2024, https://www.azonano.com/news.aspx?newsID=29896.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.